Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.418 EUR | -0.47% | -1.38% | -27.58% |
04-11 | Valneva: Deep Track Biotechnology Master holds less than 5% of the capital | CF |
03-26 | Valneva Kicks Off Early-stage Trial for Zika Vaccine Candidate | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.58% | 511M | |
+22.81% | 46.81B | |
+46.56% | 41.29B | |
-1.88% | 41.37B | |
-6.20% | 28.87B | |
+11.33% | 26.06B | |
-21.00% | 19.13B | |
-1.43% | 11.96B | |
+30.73% | 12.39B | |
-0.48% | 12.08B |
- Stock Market
- Equities
- VLA Stock
- News Valneva
- Valneva : Signs Chikungunya Vaccine Production Deal with Instituto Butantan